Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DGKE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TIMM9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LGALSL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NTHL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDIA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCAS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF275 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LSR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRELD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OCIAD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2BC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF165 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GYG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM210A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2AC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZCCHC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on